BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16679868)

  • 1. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.
    Yang HP; Woodson K; Taylor PR; Pietinen P; Albanes D; Virtamo J; Tangrea JA
    Eur J Cancer Prev; 2006 Jun; 15(3):249-53. PubMed ID: 16679868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland).
    Kamangar F; Abnet CC; Hutchinson AA; Newschaffer CJ; Helzlsouer K; Shugart YY; Pietinen P; Dawsey SM; Albanes D; Virtamo J; Taylor PR
    Cancer Causes Control; 2006 Feb; 17(1):117-25. PubMed ID: 16411061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.
    Duymaz-Tozkir J; Yilmaz V; Uyar FA; Hajeer AH; Saruhan-Direskeneli G; Gül A
    J Rheumatol; 2005 Jan; 32(1):93-7. PubMed ID: 15630732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
    Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
    Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
    Smith KC; Bateman AC; Fussell HM; Howell WM
    Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
    Kamali-Sarvestani E; Aliparasti MR; Atefi S
    Neoplasma; 2007; 54(6):484-9. PubMed ID: 17949231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MUC1 genetic variation on prostate cancer risk and survival.
    Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
    Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
    Kesarwani P; Mandhani A; Mittal RD
    J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
    Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ
    Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
    Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR3.
    Kato H; Tsuchiya N; Tokunaga K
    Genes Immun; 2000 Jun; 1(5):330-7. PubMed ID: 11196695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of multiple sclerosis in Iranian patients.
    Kamali-Sarvestani E; Nikseresht AR; Aliparasti MR; Vessal M
    Neurosci Lett; 2006 Aug; 404(1-2):159-62. PubMed ID: 16793206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
    Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
    Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.